Results 251 to 260 of about 75,991 (309)
C5 complement inhibition versus FcRn modulation in generalised myasthenia gravis. [PDF]
Huntemann N+24 more
europepmc +1 more source
Efgartigimod for induction and maintenance therapy in muscle-specific kinase myasthenia gravis. [PDF]
Zhou Y+12 more
europepmc +1 more source
Efficacy and Safety of Efgartigimod for Patients With Myasthenia Gravis in a Real-World Cohort of 77 Patients. [PDF]
Hao S+12 more
europepmc +1 more source
Ravulizumab and Efgartigimod in Myasthenia Gravis: A Real-World Study. [PDF]
Stascheit F+16 more
europepmc +1 more source
Efgartigimod Followed by Telitacicept in Adult Generalized Myasthenia Gravis: A Retrospective Case Series. [PDF]
Zhang Y+11 more
europepmc +1 more source
Health care costs and resource utilization among patients with myasthenia gravis in the United States. [PDF]
Choi SA, Touchette DR, Kim K.
europepmc +1 more source